Avidity Biosciences, Inc Cash Flow Reinvestment Rate

Latest as of December 2023: 0.05x

Avidity Biosciences, Inc cash flow reinvestment rate. Avidity Biosciences, Inc (RNAM) has a Cash Flow Reinvestment Rate of 0.05x as of December 2023, reinvesting $863.00K (capex $863.00K ) from operating cash flow of $16.50 Million. Explore RNAM cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

$863.00K
Capex + Investments

Operating Cash Flow

$16.50 Million
USD

Capital Expenditures

$863.00K
USD

Cash Flow Reinvestment Rate of Avidity Biosciences, Inc (2019–2019)

Cash flow reinvestment rate of Avidity Biosciences, Inc from 2019 to 2019. Historical reinvestment intensity for Avidity Biosciences, Inc across 1 annual periods. Explore RNAM capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Avidity Biosciences, Inc Cash Flow Reinvestment Rate by Year (2019–2019)

Avidity Biosciences, Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Avidity Biosciences, Inc. For the full cash flow conversion analysis, see how efficiently does Avidity Biosciences, Inc generate cash.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.09x $235.00K $2.49 Million $235.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow